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Staphylococci may cause severe infections in children 
and immunocompromised adults (1). Staphylococ-
cal scalded skin syndrome (SSSS), for example, is a 
potentially life-threatening disease caused by the hae-
matogenous spread of exfoliative toxins (ET) of Stap-
hylococcus aureus termed ET-A, ET-B or ET-D (2) and 
encoded by the respective chromosomal (eta, etd) and 
plasmid located genes (etb) (3); bullous impetigo (BI), 
on the other hand, results from the local impact of the 
very same exfoliatins. We report here a case of a SSSS 
caused by a rare ET-A-producing S. aureus strain in an 
adult woman affected by chronic lymphocytic B-cell 
leukaemia (CLBCL). 
CASE REPORT
A 63-year-old woman presented with fever and a bul-
lous skin eruption. She reported the intake of antibiotics 
one week earlier (amoxicillin and sulbactam) because 
of an upper airway infection. Her past medical history 
was remarkable for CLBCL, currently being treated 
with Ibrutinib. The patient had vesiculobullous lesions 
on an inflamed basis on her face, neck, trunk and left 
arm (Fig. 1A, B). Only a few blisters were intact; most 
were ruptured. Differential diagnoses included SSSS, 
a generalized variant of BI, toxic epidermal necrolysis 
(TEN), pemphigus vulgaris (PV) and toxic erythema of 
chemotherapy (TEC).
Physical examination revealed fever (38°C) and cre-
pitation on thorax auscultation. A chest X-ray was diag-
nostic for pneumonia of the left lower lobe. The Tzanck 
test from a bullous lesion showed acantholytic cells with 
no sign of necrosis, making TEN unlikely. The Nikolsky 
sign was positive on clinically normal-appearing skin. 
Primary laboratory findings revealed elevated C-reactive 
protein of 20.88 mg/dl (normal < 0.5)  and 9% relative 
band neutrophils (normal 3.0–5.0%). We observed hy-
poimmunoglobulinaemia, with IgG 340.0 mg/dl (normal 
700–160), IgA 28.5 mg/dl (normal 70–400) and IgM 6.6 
mg/dl (NR, 40–230).
Perilesional histology of a fresh bulla showed a neu-
trophilic infiltrate in the upper dermis, spongiosis and 
acantholytic split formation in 
the stratum granulosum (Fig. 
2A). A search for pemphigus 
antibodies yielded negative 
results. A gram stain of lesional 
skin revealed gram+ cocci in 
the split (Fig 2B). Bacterial 
cultures from blood and sputum, 
as well as swabs of the nose and 
lesional skin, were positive for 
methicillin-sensitive S. aureus 
(MSSA). DNA sequencing of 
the S. aureus-specific staphy-
lococcal protein A (spa) and 
multi-locus sequence-typing 
(MLST) revealed spa-type t729, 
sequence type (ST) 88 for all 
isolates. Strains were positive 
for the gene encoding the exfo-
liative toxin A (eta). A diagno-
sis of SSSS was made and the 
patient received intravenous 
piperacillin-sulbactam (4.5 g i.v. 
3 times daily for 10 days) until 
complete remission (Fig. 1B). 
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Fig. 1. Clinical course. (A) Flaccid bullae formation of face, neck, trunk and left arm. (B) Twenty days 
after initiation of antimicrobial therapy, lesions were healed without scarring. A written permission from 
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DISCUSSION 
ET-A producing MSSA with spa-type t729/ST88 are ex- 
tremely rare in Europe. The National Reference Center 
for Staphylococci and Enterococci in Germany reported 
68 cases of SSSS in the period 2014–2015, among 
which none of the ET-A-positive S. aureus strains were 
affiliated with spa-type t729. A French study of 349 
cases of SSSS (in the period 1997–2007) reported no 
t729 strain (4). Among S. aureus nasal carriage studies 
performed in Germany and the Netherlands, only one 
strain with similar characteristics was reported in the 
community (5).
S. aureus strains ST88 are found more frequently in 
African countries and, in addition to MSSA, methicil-
lin- resistant isolates are also reported (6).
The occurrence of SSSS in our patient was probably 
not fortuitous. Recent evidence suggests an impaired 
bactericidal function of polymorphonuclear cells in 
patients affected by CLL (7), potentially explaining 
the susceptibility to gram+ septicaemia. Moreover, an 
impaired humoral response favours the septic spread 
of S. aureus both in children and immunocompromised 
adults (8). Therapeutic strategies to cure SSSS using in-
travenous immunoglobulins or direct elimination of the 
Toxin via Plasma exchange have proved successful (9, 
10). A recent report suggests a role of Langerhans cells 
in providing a pre-emptive humoral protection against 
surface exfoliatin toxins, even before they can breach 
the tight junction causing systemic disease (11). Topi-
cal vaxination strategier that take advantage of antigen 
presentation through tight junktion by Langerhans cells 
might be useful in reducing the incidence of SSSS in 
immunocompromised patients and children.
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Fig. 2. Perilesional histology of a fresh blister. (A) Haematoxylin and eosin (H&E) stain of a paraffin-embedded skin biopsy (upper left). Higher 
magnification reveals an exposed granular layer (upper right), spongiosis and subcorneal split formation (lower left), as well as a dense neutrophilic 
infiltration of the papillary dermis (lower right). (B) Gram stain of the skin biopsy showing Gram-positive cocci.
